Keystone Financial Group (Kentucky)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Keystone Financial Group (Kentucky)'s GILD Position: Q1 2026 in Review
Keystone Financial Group (Kentucky) reduced its Gilead Sciences (GILD) stake by 12% in Q1 2026, selling an estimated $72.7K and leaving 3,863 shares worth $537K. The position accounts for 0.04% of the portfolio, ranked #287.
Keystone Financial Group (Kentucky) first reported a position in GILD in Q4 2017 and has held it in 20 quarters since. The position peaked at $538K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Keystone Financial Group (Kentucky) held 3,863 shares of Gilead Sciences worth $537K as of Q1 2026.
- Keystone Financial Group (Kentucky) sold 519 Gilead Sciences shares in Q1 2026, an estimated $72.7K.
- Gilead Sciences made up 0.04% of Keystone Financial Group (Kentucky)'s portfolio in Q1 2026, its #287 holding.
- Keystone Financial Group (Kentucky) first reported a position in Gilead Sciences in Q4 2017 and has held it in 20 quarters since.
- Keystone Financial Group (Kentucky)'s Gilead Sciences position peaked at $538K in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Keystone Financial Group (Kentucky)'s 13F filing for Q1 2026, filed 13 May 2026.